Crinetics Pharmaceuticals, Inc. (CRNX)
37.48
-6.01
(-13.82%)
USD |
NASDAQ |
May 08, 16:00
36.90
-0.58
(-1.55%)
After-Hours: 20:00
Crinetics Pharmaceuticals Shareholders Equity (Quarterly) : 1.281B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amneal Pharmaceuticals, Inc. | -45.41M |
| Aquestive Therapeutics, Inc. | -33.66M |
| Merck & Co., Inc. | 45.88B |
| Nektar Therapeutics | 576.22M |
| Prestige Consumer Healthcare, Inc. | 1.829B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.401B |
| Total Liabilities (Quarterly) | 120.68M |
| Debt to Equity Ratio | 0.0374 |
| Current Ratio | 18.60 |
| Net Debt Paydown Yield | 0.02% |